PLCg2 and phospholipase A1 pathways may converge to reduce the risk of Alzheimer's disease
September 21, 2026
September 21, 2026
KUOPIO, Finland, Sept. 21 -- The University of Eastern Finland posted the following news:
* * *
PLCg2 and phospholipase A1 pathways may converge to reduce the risk of Alzheimer's disease
*
Two studies involving researchers at the University of Eastern Finland highlight a central role for the PLCg2 signalling pathway in Alzheimer's disease. Protective PLCG2 variants, encoding the signalling enzyme PLCg2, were found to delay disease ons . . .
* * *
PLCg2 and phospholipase A1 pathways may converge to reduce the risk of Alzheimer's disease
*
Two studies involving researchers at the University of Eastern Finland highlight a central role for the PLCg2 signalling pathway in Alzheimer's disease. Protective PLCG2 variants, encoding the signalling enzyme PLCg2, were found to delay disease ons . . .
